Chinas Tungsten Exports to Japan Drop by Half as Export Controls Tighten
LongTerm Potential of AI Stocks A Decade Outlook
Vestas Wind Systems Shares Decline After Margin Guidance Update
Signos Raises 20M in Funding Partners with Dexcom to Expand AIPowered Weight Loss Platform
Ashok Leyland Reports Stabilizing Ras Al Khaimah Operations Saudi Manufacturing Plans on Schedule
Microsoft Names Jenny LayFlurrie to Lead Trusted Technology Amid AI Speed vs Responsibility Debate
CDZIP Q1 2026 Earnings Narrower Loss Beats Estimates Stock Rises 36
YTRA Q1 2026 Earnings Narrower Loss than Expected Shares Rally 6
KWR Q1 2026 Earnings EPS Misses Estimates by a Slim Margin Stock Edges Lower
Brighthouse Financial Q1 2026 Earnings Insurance Giant Misses EPS Estimates Amid Market Volatility
First Seacoast Bancorp FSEA Q3 2024 Earnings Modest Profit Despite Quiet Quarter
TOWN Q1 2026 Earnings EPS Misses Estimates by Nearly 5 Stock Edges Lower
Nova Minerals NVA Declines Over 5 as Support Levels Near
BULLW Warrants Slide 954 as Webulls Equitylinked Securities Test Key Support
Masco Corporation MAS Advances Amid Sector Strength Key Resistance in Focus
Netcapital Inc NCPL Holds Steady Near Support After Minimal Decline
Ralph Lauren RL Edges Higher Key Levels to Watch After Modest Gain
OOMA Q1 2026 Earnings EPS Surpasses Estimates with 786 Beat
ONB Q1 2026 Earnings Narrow EPS Miss Slightly Below Estimates Stock Edges Higher
AXR Q1 2026 Earnings Slight EPS Beat Marks a Quiet Quarter
JHG Q1 2026 Earnings EPS Misses Estimates Amid Market Headwinds
HESM Q1 2026 Earnings EPS Beat of 325 Drives Modest Stock Gain
CBRE Q1 2026 Earnings Stellar EPS Beat Underscores Resilient Business Model
OpenAI Poised to Lead AI IPO Race with Confidential Filing Report
PROCEPT BioRobotics Q1 2026 Earnings NarrowerThanExpected Loss Signals Progress
LB Pharmaceuticals LBRX Holds Near Resistance as Modest Gain Signals Consolidation
SSP Q1 2026 Earnings EPS Surpasses Expectations by 619 as Cost Controls Drive Profitability
ATOS Q1 2026 Earnings Narrowing Loss Exceeds Expectations Amid Clinical Progress
Penumbra Q1 2026 Earnings EPS Misses Estimates by 245 Amidst Operational Headwinds
VELO Q1 2026 Earnings Strong EPS Beat Shocks Market Revenue Remains Undisclosed
CNTB Q1 2026 Earnings WiderthanExpected Loss as Development Pipeline Advances
Eikon Therapeutics Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline
AUTL Q1 2026 Earnings Biotech Posts WiderThanExpected Loss as Stock Edges Higher